ID: ALA4788330

Max Phase: Preclinical

Molecular Formula: C35H40BrO4P

Molecular Weight: 555.68

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(OCCCCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1cccc(O)c1O.[Br-]

Standard InChI:  InChI=1S/C35H39O4P.BrH/c36-33-26-18-25-32(34(33)37)35(38)39-27-16-5-3-1-2-4-6-17-28-40(29-19-10-7-11-20-29,30-21-12-8-13-22-30)31-23-14-9-15-24-31;/h7-15,18-26H,1-6,16-17,27-28H2,(H-,36,37,38);1H

Standard InChI Key:  IQGHTZJMVJCGGL-UHFFFAOYSA-N

Associated Targets(Human)

CAL-27 814 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEp-2 3859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SCC-15 194 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 555.68Molecular Weight (Monoisotopic): 555.2659AlogP: 7.37#Rotatable Bonds: 15
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.27CX Basic pKa: CX LogP: 9.72CX LogD: 9.71
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.07Np Likeness Score: 0.15

References

1. CatalAn, Mabel, Castro-Castillo, Vicente, Gajardo-de la Fuente, Javier, Aguilera, Jocelyn, Ferreira, Jorge, Ramires-Fernandez, Ricardo, Olmedo, Ivonne, Molina-Berrios, Alfredo, Palominos, Charlotte, Valencia, Marcelo, Dominguez, Marta, Souto, Jose A., Jara, Jose A..  (2020)  Continuous flow synthesis of lipophilic cations derived from benzoic acid as new cytotoxic chemical entities in human head and neck carcinoma cell lines,  11  (10): [PMID:33479625] [10.1039/d0md00153h]

Source